Fig. 1From: DUPAN-II normalisation as a biological indicator during preoperative chemoradiation therapy for resectable and borderline resectable pancreatic cancerOverall survival of the patients with sufficiently elevated DUPAN-II levels, i.e. 1.5, 2, 2.5, and 3 times the upper normal limit of DUPAN-II (150 U/ml); DUPAN-II > 230, 300, 380, and 450 U/mlBack to article page